Sleep is a biological necessity with measurable neurobiological functions — memory consolidation, emotional regulation reset via REM processing, glymphatic clearance, immune regulation, and hormonal entrainment — that cannot occur outside of sleep. Treating it as a lifestyle variable is a clinical error.
The neurobiological effects of sleep deprivation are significant: a single night of insufficient sleep increases amygdala reactivity by up to 60% and reduces prefrontal cortical modulation (Yoo et al., 2007), producing a state neurologically indistinguishable from anxiety. Chronic sleep deprivation is associated with elevated risk of depression, anxiety disorders, cognitive impairment, and dementia.
Chronic insomnia is maintained by conditioned arousal, cognitive hyperarousal, and compensatory behaviours — not poor sleep habits. Standard sleep hygiene addresses conditions, not mechanisms. CBT-I (Cognitive Behavioural Therapy for Insomnia) is the most evidence-based treatment for chronic insomnia, recommended as first-line ahead of sleep medication by the American College of Physicians, European Sleep Research Society, and NICE (Qaseem et al., 2016). Its core components — sleep restriction, stimulus control, cognitive restructuring, relaxation — produce more durable improvement than medication.
The sleep-mental health spiral (poor sleep worsens mood; poor mood worsens sleep) requires simultaneous rather than sequential treatment of both dimensions. The OASIS trial (Freeman et al., 2017, Lancet Psychiatry) demonstrated that treating insomnia in a mental health population reduced depression, anxiety, paranoia, and hallucinations across the board.
Additional evidence-based interventions covered: morning light therapy for circadian entrainment (Lam et al., 2016), extended exhale breathing for autonomic downregulation, and sleep medication appropriately framed as a bridge rather than a solution. Neurodivergent-specific mechanisms addressed — melatonin differences in autism, delayed sleep phase in ADHD. Perimenopausal sleep disruption addressed via vasomotor and HPA axis mechanisms.
Dr Melanie du Preez | HPCSA-registered Clinical Psychologist | 26 years clinical experience | Founder, Mindpath Academy | Maudsley/FBT-certified | Specialisations: neurodivergence, trauma, burnout, LGBTQ+ mental health